Bioextrax AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 0.275 million compared to SEK 0.12 million a year ago. Revenue was SEK 0.275 million compared to SEK 0.488 million a year ago. Net loss was SEK 5.5 million compared to SEK 4.6 million a year ago. Basic loss per share from continuing operations was SEK 0.21 compared to SEK 0.29 a year ago. Diluted loss per share from continuing operations was SEK 0.21 compared to SEK 0.29 a year ago.
For the nine months, sales was SEK 1.25 million compared to SEK 0.363 million a year ago. Revenue was SEK 2.15 million compared to SEK 1.41 million a year ago. Net loss was SEK 15.27 million compared to SEK 12.87 million a year ago. Basic loss per share from continuing operations was SEK 0.6 compared to SEK 0.85 a year ago. Diluted loss per share from continuing operations was SEK 0.6 compared to SEK 0.85 a year ago.